FHTX

MKT CAP:$233M

Foghorn Therapeutics Inc

Market Cap

$233M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.73-$1.46 (-28.13%)

Jun 5, 2026

52W High $6.6852W Low $3.53

Company Details

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The comp...

CEO

—

IPO Date

Oct 23, 2020

Website

foghorntx.com

Key Metrics TTM

Revenue

$28M

+20.1% YoY

Net Income

-$75M

EPS (Diluted)

Free Cash Flow

-$87M

Revenue / Share

$0.41

Gross Margin

22.3%

Operating Margin

-286.2%

Net Margin

-266.9%

FCF Margin

-309.7%

P/S

8.3x

P/E

Earnings Reports

Q1 2026

May 7, 2026

$3M-45.1%

FY 2025

Mar 11, 2026

$31M+36.8%

Q4 2025

Mar 11, 2026

$9M+223.8%

Q3 2025

Nov 5, 2025

$8M+4.4%

Q2 2025

Aug 5, 2025

$8M+9.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee